Carisma Therapeutics Inc. Net Asset Quality Index
Carisma Therapeutics Inc. net asset quality index. Carisma Therapeutics Inc. (CARM) has a Net Asset Quality Index of -13.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $6.55 Million minus total liabilities of $7.42 Million yields net assets of $-867.00K. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Carisma Therapeutics Inc. for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Carisma Therapeutics Inc. (2011–2024)
Net asset quality index of Carisma Therapeutics Inc. from 2011 to 2024. This chart shows how Carisma Therapeutics Inc.'s Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the index stands at -13.2%, representing net assets of $-867.00K against total assets of $6.55 Million USD. Check Carisma Therapeutics Inc. PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Carisma Therapeutics Inc. Net Asset Quality Index by Year (2011–2024)
Carisma Therapeutics Inc. net asset quality index by year from 2011 to 2024. The table below presents the year-by-year Net Asset Quality Index for Carisma Therapeutics Inc. from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CARM market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -91.6% | $-27.91 Million | $30.46 Million | $58.37 Million | ▼ -121.3 pp |
| 2023 | 29.6% | $26.53 Million | $89.55 Million | $63.02 Million | ▲ +227.4 pp |
| 2022 | -197.7% | $-142.67 Million | $72.15 Million | $214.82 Million | ▼ -252.7 pp |
| 2021 | 54.9% | $171.71 Million | $312.60 Million | $140.89 Million | ▲ +59.8 pp |
| 2020 | -4.9% | $-9.23 Million | $188.45 Million | $197.68 Million | ▲ +18.5 pp |
| 2019 | -23.3% | $-26.70 Million | $114.36 Million | $141.06 Million | ▼ -63.0 pp |
| 2018 | 39.6% | $44.21 Million | $111.56 Million | $67.35 Million | ▲ +15.6 pp |
| 2017 | 24.0% | $18.03 Million | $75.10 Million | $57.06 Million | ▼ -13.1 pp |
| 2016 | 37.2% | $38.68 Million | $104.10 Million | $65.42 Million | ▼ -14.3 pp |
| 2015 | 51.4% | $18.94 Million | $36.83 Million | $17.88 Million | ▼ -15.5 pp |
| 2014 | 67.0% | $36.83 Million | $55.00 Million | $18.17 Million | ▲ +46.1 pp |
| 2013 | 20.9% | $2.35 Million | $11.24 Million | $8.89 Million | ▼ -39.5 pp |
| 2012 | 60.4% | $5.74 Million | $9.50 Million | $3.76 Million | ▲ +65.9 pp |
| 2011 | -5.5% | $-147.00K | $2.67 Million | $2.81 Million | — |